Nymox Pharmaceutical Corporation NYMX

Annual report 2024
added 02-21-2026

Nymox Pharmaceutical Corporation DIO Ratio 2011-2026 | NYMX

Annual DIO Ratio Nymox Pharmaceutical Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	5.46	85.7	186	29.8	61.1	29.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
186	5.46	66.2

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Kamada Ltd. KMDA	166	$ 8.81	1.73 %	$ 260 M	Israel
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Aptorum Group Limited APM	4.89	$ 0.79	-1.29 %	$ 4.31 M	China
	XTL Biopharmaceuticals Ltd. XTLB	149	$ 0.88	-1.43 %	$ 442 M	Israel
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Arena Pharmaceuticals ARNA	160	-	-6.81 %	$ 3.04 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Aytu BioScience AYTU	209	$ 2.36	2.27 %	$ 14.8 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	Codexis CDXS	50.2	$ 1.17	-0.85 %	$ 85.9 M	USA
	Amneal Pharmaceuticals AMRX	123	$ 14.49	-0.75 %	$ 4.48 B	USA